The role of natriuretic peptides in volume assessment and mortality prediction in Haemodialysis patients

BMC Nephrology

Volumn 16, Issue 1, 2015, Pages

  Sivalingam, Murugan ^a   Vilar, Enric ^a   Mathavakkannan, Suresh ^a   Farrington, Ken ^a  

^a LISTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CENTRAL VENOUS PRESSURE; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; CRACKLE; CROSS-SECTIONAL STUDY; EXTRACELLULAR SPACE; FEMALE; FOLLOW UP; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PERIPHERAL EDEMA; PREVALENCE; PROTEIN BLOOD LEVEL; RELIABILITY; SURVIVAL TIME; BLOOD; BODY FLUID; CARDIOVASCULAR DISEASE; HEMODIALYSIS; MORTALITY; PROGNOSIS; RISK FACTOR;

AGED; ATRIAL NATRIURETIC FACTOR; BODY FLUIDS; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; RENAL DIALYSIS; RISK FACTORS;

EID: 84951915239     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/s12882-015-0212-4     Document Type: Article

References (41)

1. Tapolyai M, Faludi M, Reti V, Lengvarszky Z, Szarvas T, Fulop T, et al. Volume estimation in dialysis patients: the concordance of brain-type natriuretic peptide measurements and bioimpedance values. Hemodial Int. 2013;17:406-12.
2. van de Pol AC, Frenken LA, Moret K, Baumgarten R, van der Sande FM, Beerenhout CM, et al. An evaluation of blood volume changes during ultrafiltration pulses and natriuretic peptides in the assessment of dry weight in hemodialysis patients. Hemodial Int. 2007;11:51-61.
3. Paniagua R, Ventura MD, Avila-Diaz M, Hinojosa-Heredia H, Mendez-Duran A, Cueto-Manzano A, et al. NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients. Nephrol Dial Transplant. 2010;25:551-7.
4. Fagugli RM, Palumbo B, Ricciardi D, Pasini P, Santirosi P, Vecchi L, et al. Association between brain natriuretic peptide and extracellular water in hemodialysis patients. Nephron Clin Pract. 2003;95:c60-6.
5. Nakao K, Ogawa Y, Suga S, Imura H. Molecular biology and biochemistry of the natriuretic peptide system. I: Natriuretic peptides. J Hypertens. 1992;10:907-12.
6. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation. 1994;90:195-203.
7. Yoshimura M, Yasue H, Okumura K, Ogawa H, Jougasaki M, Mukoyama M, et al. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation. 1993;87:464-9.
8. Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol. 2007;50:2357-68.
9. Koller KJ, Goeddel DV. Molecular biology of the natriuretic peptides and their receptors. Circulation. 1992;86:1081-8.
10. Norman JA, Little D, Bolgar M, Di DG. Degradation of brain natriuretic peptide by neutral endopeptidase: species specific sites of proteolysis determined by mass spectrometry. Biochem Biophys Res Commun. 1991; 175:22-30.
11. Bonow RO. New insights into the cardiac natriuretic peptides. Circulation. 1996;93:1946-50.
12. Eisenhauer T, Talartschik J, Scheler F. Detection of fluid overload by plasma concentration of human atrial natriuretic peptide (h-ANP) in patients with renal failure. Klin Wochenschr. 1986;64 Suppl 6:68-72.
13. de Chatel R, Mako J, Toth M, Barna I, Lang RE. Atrial natriuretic peptide (ANP) in patients with chronic renal failure on maintenance haemodialysis. Int Urol Nephrol. 1991;23:177-83.
14. Eisenhauer T, Talartschik J, Quentin E, Kreutzfeldt W, Scheler F. Modification of atrial natriuretic peptide (ANP) and cyclic GMP by hemofiltration and hemodialysis. Klin Wochenschr. 1988;66:940-5.
15. Franz M, Woloszczuk W, Horl WH. N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment. Kidney Int. 2000;58:374-83.
16. Saxenhofer H, Gnadinger MP, Weidmann P, Shaw S, Schohn D, Hess C, et al. Plasma levels and dialysance of atrial natriuretic peptide in terminal renal failure. Kidney Int. 1987;32:554-61.
17. Wolfram G, Sitter T, Gottsmann M, Gerzer R, Schiffl H. Assessment of dry weight in haemodialysis patients by the volume markers ANP and cGMP. Nephrol Dial Transplant. 1996;11 Suppl 2:28-30.
18. Lee SW, Song JH, Kim GA, Lim HJ, Kim MJ. Plasma brain natriuretic peptide concentration on assessment of hydration status in hemodialysis patient. Am J Kidney Dis. 2003;41:1257-66.
19. Nitta K, Kawashima A, Yumura W, Naruse M, Oba T, Kabaya T, et al. Plasma concentration of brain natriuretic peptide as an indicator of cardiac ventricular function in patients on hemodialysis. Am J Nephrol. 1998;18:411-5.
20. Booth J, Pinney J, Davenport A. N-terminal proBNP-marker of cardiac dysfunction, fluid overload, or malnutrition in hemodialysis patients? Clin J Am Soc Nephrol. 2010;5:1036-40.
21. Zoccali C, Mallamaci F, Benedetto FA, Tripepi G, Parlongo S, Cataliotti A, et al. Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol. 2001; 12:1508-15.
22. Wahl HG, Graf S, Renz H, Fassbinder W. Elimination of the cardiac natriuretic peptides B-type natriuretic peptide (BNP) and N-terminal proBNP by hemodialysis. Clin Chem. 2004;50:1071-4.
23. Mathavakkannan S. Techniques to Assess Volume Status and Haemodynamic Stability in Haemodialysis Patients, PhD thesis. UK: University of Hertfordshire; 2009.
24. Charlson ME, Pompei P, Ales KL, Mackenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-83.
25. Chamney PW, Kramer M, Rode C, Kleinekofort W, Wizemann V. A new technique for establishing dry weight in hemodialysis patients via whole body bioimpedance. Kidney Int. 2002;61:2250-8.
26. Chanchairujira T, Mehta RL. Assessing fluid change in hemodialysis: whole body versus sum of segmental bioimpedance spectroscopy. Kidney Int. 2001;60:2337-42.
27. Chen YC, Chen HH, Yeh JC, Chen SY. Adjusting dry weight by extracellular volume and body composition in hemodialysis patients. Nephron. 2002;92: 91-6.
28. Onofriescu M, Hogas S, Voroneanu L, Apetrii M, Nistor I, Kanbay M, et al. Bioimpedance-guided fluid management in maintenance hemodialysis: a pilot randomized controlled trial. Am J Kidney Dis. 2014;64:111-8.
29. Moissl U, Arias-Guillen M, Wabel P, Fontsere N, Carrera M, Campistol JM, et al. Bioimpedance-guided fluid management in hemodialysis patients. Clin J Am Soc Nephrol. 2013;8:1575-82.
30. Vickery S, Price CP, John RI, Abbas NA, Webb MC, Kempson ME, et al. B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy. Am J Kidney Dis. 2005;46:610-20.
31. Sivalingam M, Suresh M, Farrington K. Comparison of B-type natriuretic peptide and NT proBNP as predictors of survival in patients on high-flux hemodialysis and hemodiafiltration. Hemodial Int. 2011;15:359-65.
32. Suresh M, Farrington K. Natriuretic peptides and the dialysis patient. Semin Dial. 2005;18:409-19.
33. Horl WH. Natriuretic peptides in acute and chronic kidney disease and during renal replacement therapy. J Investig Med. 2005;53:366-70.
34. Metry G, Hall C, Wikstrom B, Kallskog V, Hansell P, Danielson B. Fluid balance in patients with chronic renal failure assessed with N-terminal proatrial natriuretic peptide, atrial natriuretic peptide and ultrasonography. Acta Physiol Scand. 2001;171:117-22.
35. McIntyre CW. Haemodialysis-induced myocardial stunning in chronic kidney disease-a new aspect of cardiovascular disease. Blood Purif. 2010; 29:105-10.
36. Jansen MA, Hart AA, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int. 2002;62:1046-53.
37. Chang TI, Paik J, Greene T, Desai M, Bech F, Cheung AK, et al. Intradialytic hypotension and vascular access thrombosis. J Am Soc Nephrol. 2011;22: 1526-33.
38. Satyan S, Light RP, Agarwal R. Relationships of N-terminal pro-B-natriuretic peptide and cardiac troponin T to left ventricular mass and function and mortality in asymptomatic hemodialysis patients. Am J Kidney Dis. 2007;50: 1009-19.
39. Sun L, Sun Y, Zhao X, Xu C, Chen D, Li L, et al. Predictive role of BNP and NT-proBNP in hemodialysis patients. Nephron Clin Pract. 2008;110:c178-84.
40. Sommerer C, Beimler J, Schwenger V, Heckele N, Katus HA, Giannitsis E, et al. Cardiac biomarkers and survival in haemodialysis patients. Eur J Clin Invest. 2007;37:350-6.
41. Voroneanu L, Siriopol D, Nistor I, Apetrii M, Hogas S, Onofriescu M, et al. Superior predictive value for NTproBNP compared with high sensitivity cTnT in dialysis patients: a pilot prospective observational study. Kidney Blood Press Res. 2014;39:636-47.